CONMED Corp(CNMD)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

CONMED Corp (CNMD) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CNMD at 48.7/100 on a 32-signal composite quality model, placing it at rank #1,708 of 2,961 stocks — the bottom half of the AI-ranked universe. CNMD scores in the top quartile across earnings quality (87.7). Areas of concern include institutional flow (23.6) and profitability (35.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 39.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), CONMED Corp reports quarterly revenue of $343.5M, net income of $23.1M, an operating margin of 10.6%. Top institutional holders of CNMD by reported 13-F value include BlackRock, EARNEST PARTNERS, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. CNMD trades on the NYSE exchange and files with the SEC under CIK 816956. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CNMD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CONMED Corp directly from SEC EDGAR.